Charles River Laboratories | CRL - Себестоимость

Биржевая цена
166.97
Изменение за день
3.13 1.91%
Ежемесячно
-3.21%
Ежегодный
42.84%
Q2 прогноз
166.17




Себестоимость Изменить Дата
Agilent USD 852M 19M 2025-12
Align Technology USD 303.5M 60.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 528M 46.9M 2025-12
Cardinal Health USD 63.36B 1.57B 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cigna USD 66.52B 3.15B 2025-12
Concord Medical Services Hldg CNY 204.9M 117.04M 2025-06
CVS Health USD 92.13B 3.06B 2025-12
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 518M 55M 2025-12
Elevance Health USD 38.07B 75M 2025-12
Galapagos EUR 455K 84.28M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 400M 49M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Lonza CHF 2.28B 189M 2025-06
McKesson USD 102.47B 2.86B 2025-12
Merck EUR 2.29B 183M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Revvity USD 350.4M 26.05M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
United Therapeutics USD 474.7M 373.8M 2025-12
UnitedHealth USD 94.72B 2.2B 2025-12
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 548.5M 47.4M 2026-03